0001737287 2026-08-06 2026-08-06 0001737287 1 2026-08-06 2026-08-06 0001737287 2 2026-08-06 2026-08-06 0001737287 3 2026-08-06 2026-08-06 0001737287 4 2026-08-06 2026-08-06 0001737287 5 2026-08-06 2026-08-06 iso4217:USD pure S-3 S-3 EX-FILING FEES 0001737287 Allogene Therapeutics, Inc. N/A N/A 0.0001381 0.0001381 0.0001381 0.0001381 S-3 Allogene Therapeutics, Inc. Equity Common Stock, par value $0.001 per share true Equity Preferred Stock, par value $0.001 per share true Debt Debt Securities true Other Warrants true false Unallocated (Universal) Shelf true 500000000.00 0.0001381 69050.00 500000000.00 69050.00 0.00 0.00 69050.00 a. There are being registered hereunder such indeterminate number of shares of common stock, such indeterminate number of shares of preferred stock, such indeterminate principal amount of debt securities and such indeterminate number of warrants to purchase common stock, preferred stock or debt securities as shall have an aggregate initial offering price not to exceed $500,000,000. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $500,000,000, less the aggregate dollar amount of all securities previously issued hereunder. The securities registered also include such indeterminate amount of all securities previously issued hereunder. The securities registered also include such indeterminate number of shares of common stock, preferred stock and amount of debt securities as may be issued upon conversion of or exchange for debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. b. The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A.iii.b under the heading "Instructions to the Calculation of Filing Fee Tables and Related Disclosure" of Part II, Item 16, of Form S-3 under the Securities Act.